中国继续医学教育
中國繼續醫學教育
중국계속의학교육
CHINA CONTINUING MEDICAL EDUCATION
2015年
2期
148-149
,共2页
抗组胺药%慢性特发性荨麻疹%疗效
抗組胺藥%慢性特髮性蕁痳疹%療效
항조알약%만성특발성담마진%료효
Antihistamines%Chronic idiopathic urticaria%The curative effect
目的：评价3种抗组胺药治疗慢性特发性荨麻疹的疗效。方法选取于我院就诊的慢性特发性荨麻疹患者90例作为研究对象，随机分为三组，每组各30人，分别给予西替利嗪药物治疗、氯雷他定药物治疗、依巴斯丁药物治疗。结果第7天、14天、28天三组有效率为：氯雷他定组分别为70.00%、83.33%、93.33%；西替利嗪组分别为66.67%、86.67%、90.00%；依巴斯丁组分别为76.67%、86.67%、96.67%。结论三种抗组胺药物在临床治疗慢性特发荨麻疹上都具有较好的效果，具有临床应用价值。
目的：評價3種抗組胺藥治療慢性特髮性蕁痳疹的療效。方法選取于我院就診的慢性特髮性蕁痳疹患者90例作為研究對象，隨機分為三組，每組各30人，分彆給予西替利嗪藥物治療、氯雷他定藥物治療、依巴斯丁藥物治療。結果第7天、14天、28天三組有效率為：氯雷他定組分彆為70.00%、83.33%、93.33%；西替利嗪組分彆為66.67%、86.67%、90.00%；依巴斯丁組分彆為76.67%、86.67%、96.67%。結論三種抗組胺藥物在臨床治療慢性特髮蕁痳疹上都具有較好的效果，具有臨床應用價值。
목적：평개3충항조알약치료만성특발성담마진적료효。방법선취우아원취진적만성특발성담마진환자90례작위연구대상，수궤분위삼조，매조각30인，분별급여서체리진약물치료、록뢰타정약물치료、의파사정약물치료。결과제7천、14천、28천삼조유효솔위：록뢰타정조분별위70.00%、83.33%、93.33%；서체리진조분별위66.67%、86.67%、90.00%；의파사정조분별위76.67%、86.67%、96.67%。결론삼충항조알약물재림상치료만성특발담마진상도구유교호적효과，구유림상응용개치。
Objective To evaluate three kinds of antihistamines curative effect for the treatment of chronic idiopathic urticaria. Methods 90 patients with chronic idiopathic urticaria were selected from our hospital as research object, randomly dividing into three groups (30 people a group). Cetirizine group was given cetirizine medication, loratadine group was given loratadine drug therapy, by buss butyl group was given by buss butyl drug therapy. Results 7 days, 14 days, the effective rate of 28 days three groups:loratadine group was 70.00%, 83.33%and 70.00%respectively. Cetirizine group was 66.67%, 86.67%and 66.67%respectively. By bass butyl group 76.67%, 86.67, 96.67, respectively. Conclusion The three kinds of antihistamines in clinical treatment of chronic idiopathic urticaria had good effect, had clinical application value.
